The Centre for Molecular Medicine Norway consists of several research groups, lead by internationally recruited team leaders.
NCMM's group leaders in the Summer of 2022. From left to right: Emma Haapaniemi, Nikolina Sekulic, Marieke Kuijjer, Anthony Mathelier, Janna Saarela, Camila Esguerra, Sebastian Waszak, Charlotte Boccara, Irep Gozen and Judith Staerk. Photo: Oda Hveem/Visuello
Esguerra Group
Our research team is focused on exploring the fundamental mechanisms underlying brain function in health and disease.
Gözen Group
In our laboratory we use soft biomaterials, such as lipid membranes, to mimic the behavior of living cells.
Haapaniemi Group
Our group focuses on developing targeted therapies for rare immunological conditions, such as primary immunodeficiency diseases and immunological conditions of unknown origin.
Kuijjer Group
Our group aims to solve fundamental biological questions through the development of new methods in computational and systems biology.
Boccara Group
The Boccara group mission is to conduct innovative research projects at the junction of developmental neurobiology, system neuroscience and sleep research.
Sekulic Group
Our research group is using modern biophysical methods in combination with structural - and cell biology to answer important questions in the field of chromatin biology.
Mathelier Group
We aim to develop cutting-edge bioinformatics tools with immediate application to real-life biological problems, such as gene expression regulation and cancer.
Saarela Group
Our research focuses on improving the understanding of biological pathways and pathogenic mechanisms behind rare and common immune diseases, especially primary immune deficiencies and multiple sclerosis, and utilizing the new knowledge to benefit patients.
Sahu Group
Our goal is precision targeting of malfunctioning gene regulatory elements in human cancer and other enhanceropathies.
Waszak Group
Our group is working towards the development of precision medicine strategies for pediatric brain cancer patients.